The market value of Ropharma Brașov (IAFR) retail pharmacy network, owed by businessman Mihai Miron, has over the past four months climbed by 53m euros on the Stock Exchange, with the company currently valued at 94.1m euros. Thus, the value of the 88% stake in Ropharma Miron owns directly and indirectly has risen by 47m euros.
The drug distributor, which announced it moved to the tier 1 of
the Stock Exchange, has thus become the biggest listed
pharmaceutical company, leaving far behind companies that are
better known on the market, such as Zentiva București (SCD), which
has a 77m-euro capitalisation, Antibiotice Iași (ATB) or Biofarm
București (BIO).
“I’ve worked in the pharmaceutical industry ever since the fall of
communism and I am a little dissatisfied the pharmaceutical sector,
a star on international stock markets, has had a low profile in our
country. I hope that by listing Ropharma on the first tier of the
Stock Exchange we should stir investors’ interest in this field,”
stated Mihai Miron.